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Background: Common infectious pathogens have been associated with psychiatric disorders, self-violence and
risk-taking behavior.
Methods: This case-control study reviews register data on 81,912 individuals from the Danish Blood Donor Study
to identify individuals who have a psychiatric diagnosis (N= 2591), have attempted or committed suicide
(N=655), or have had traffic accidents (N= 2724). For all cases, controls were frequency matched by age and
sex, resulting in 11,546 participants.
Plasma samples were analyzed for immunoglobulin G (IgG) antibodies against Toxoplasma gondii and cyto-
megalovirus (CMV).
Results: T. gondii was detected in 25·9% of the population and was associated with schizophrenia (odds ratio
[OR], 1·47; 95% confidence interval [CI], 1·03–2·09). Accounting for temporality, with pathogen exposure
preceding outcome, the association was even stronger (IRR, 2·78; 95% CI, 1·27–6·09). A very weak association
between traffic accident and toxoplasmosis (OR, 1·11; 95% CI, 1·00–1·23, p= 0.054) was found.
CMV was detected in 60·8% of the studied population and was associated with any psychiatric disorder (OR,
1·17; 95% CI, 1·06–1·29), but also with a smaller group of neurotic, stress-related, and somatoform disorders
(OR, 1·27; 95% CI, 1·12–1·44), and with attempting or committing suicide (OR, 1·31; 95% CI, 1·10–1·56).
Accounting for temporality, any psychiatric disorder (IRR, 1·37; 95% CI, 1·08–1·74) and mood disorders (IRR,
1·43; 95% CI, 1·01–2·04) were associated with exposure to CMV. No association between traffic accident and
CMV (OR, 1·06; 95% CI, 0·97–1·17) was found.
Conclusions: This large-scale serological study is the first study to examine temporality of pathogen exposure and
to provide evidence of a causal relationship between T. gondii and schizophrenia, and between CMV and any
psychiatric disorder.
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1. Introduction
In recent years there has been a growing interest in the influence of
infectious agents on human behavior and mental disorders. Common
infectious pathogens such as Toxoplasma gondii (T. gondii) and cyto-
megalovirus (CMV) have been associated with psychiatric disorders,
cognitive deficits, suicidal behavior, and traffic accidents (Dickerson
et al., 2018, 2017, 2014b; Flegr et al., 2002; Flegr and Horáček, 2018;
Hamdani et al., 2017; Sutterland et al., 2015). The nature of these as-
sociations remains uncertain, but it is plausible that they reflect caus-
ality.
T. gondii is a protozoan parasite that causes the disease tox-
oplasmosis. Most exposed people experience a latent (asymptomatic)
form of the disease. However, prenatal infection with T. gondii may
cause abortion as well as a congenital syndrome that includes seizures
and severe intellectual disability (Nissen et al., 2017). Studies have
demonstrated that latent T. gondii infection may induce behavioral
changes both in animal models and in humans, possibly as part of an
evolutionary strategy dubbed the ‘parasite manipulation hypothesis’,
but the results have been inconsistent (Flegr et al., 2011; Poirotte et al.,
2016; Worth et al., 2014).
CMV is a common lifelong, latent beta herpes virus infection, and
most healthy exposed people experience a latent form of the disease,
with few or no symptoms. Congenital CMV infection may cause visual
impairment, hearing loss or cognitive impairment (Dollard et al., 2007).
Several studies have shown that infection with CMV is associated with
increased risk of psychiatric disorders such as schizophrenia, bipolar
disorder, and cognitive deficits (Dickerson et al., 2014b; Hamdani et al.,
2017). Moreover, CMV may exacerbate existing psychiatric pathology
through mechanisms including induction of pro-inflammatory cyto-
kines (e.g., interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)) or
directly via interactions with specific illness susceptibility genes
(Prossin et al., 2015).
If T. gondii and CMV infections were causally associated with in-
expedient behavior or psychiatric disorders it could have public health
as well as clinical implications, since it could offer targets for both
prevention and treatment. To this end, it is essential to establish the
direction of the association between the infectious agents and the be-
havioral and psychiatric outcomes, i.e. the sequence of events. We
therefore examined a large cohort of blood donors carefully assessed for
both T. gondii and CMV infection exposures over time, and for beha-
vioral and psychiatric outcomes.
2. Methods
2.1. Study population
The Danish Blood Donor Study (DBDS) is an ongoing national large-
scale prospective cohort of Danish blood donors, previously described
(Burgdorf et al., 2017). DBDS was initiated in March 2010 as a multi-
center, public-health study and biobank (www.dbds.dk) and by 2018
included more than 110,000 individuals between 18 and 67 years at
day of inclusion (inclusive). Data collection in DBDS employs existing
infrastructure for standardized data collection and for handling and
storage of blood samples from all Danish blood centers. The DBDS
biobank contains DNA and EDTA plasma samples, consecutive for all
donors returning for blood donation after enrolment.
2.2. Overall design
We carried out a case-control study in DBDS and a case-control
study nested in DBDS to account for temporality, i.e., the exposure
should precede the outcome of interest. Specifically, we identified all
individuals in the DBDS cohort registered with psychiatric disorders,
suicidal behavior, or traffic accidents (N=5953). All cases with psy-
chiatric disorders (1971–2013), suicidal behavior (1977–2011) and
traffic accidents (2008–2012) were included. These were frequency
matched with suitable controls (N=7101). For all identified in-
dividuals, sample immunological assays were used to provide in-
formation on past infection with T. gondii and CMV. Details follow
below.
2.3. Psychiatric diagnoses
The Danish Psychiatric Central Research Register (Mors et al., 2011)
is a nationwide computerized register. The register holds information
on all admissions to Danish psychiatric inpatient facilities since 1969
and to outpatient facilities since 1995. Psychiatric diagnoses are coded
according to the International Classification of Diseases − 8th Revision
(WHO, 1965) between 1969 and 1993 and 10th Revision (WHO, 1994)
since 1994.
Cases with any diagnosis of psychiatric disorder (ICD-10: F00-F99
and eq. ICD-8) and subgroups of cases, including schizophrenia and
related disorders (ICD-10: F20-F29 and eq. ICD-8 (Pedersen et al.,
2014)), mood disorders (ICD10: F30-F39 and eq. ICD8) and neurotic,
stress-related, and somatoform disorders (ICD-10: F40-F48 and eq. ICD-
8) before the end of 2013 were obtained. For all participants, we ob-
tained information on parental history of any psychiatric diagnosis.
2.4. Attempting and committing suicide
The Danish Register of Causes of Death (Juel and Helweg-Larsen,
1999) contains information concerning all residents who died in Den-
mark from 1970 through 2011. In Denmark, the legal regulation on
death certification states that any case of sudden and unexpected death
shall be reported to the police, and the death certificate may only be
issued after a medico-legal examination.
The Danish National Patient Register (Lynge et al., 2011) was es-
tablished in 1977 to prospectively record public hospital admissions,
and obtained nationwide coverage regarding inpatient admissions.
From 1995 it was expanded to include outpatient and emergency room
contacts, and from 2002 it includes private hospitals and private spe-
cialty clinics. Diagnoses are based on the International Classification of
Diseases 8th Revision between 1977 and 1993, and the International
Classification of Diseases –10th Revision from 1994 onward.
First episode of deliberate self‐violence and suicide were defined by
inclusion in the Danish National Patient Register (1977–2012), the
Psychiatric Central Research Register (1969–2013) or the Danish
Register of Causes of Death (1970–2011), which has previously been
used in Danish register studies (Nordentoft, 2011). In this study we
restricted the definition criteria to episodes registered after the age of
15.
2.5. Traffic accidents
Participants who had been involved in a traffic accident in the
period 2008–2012 were identified in the Danish National Patient
Register or in the Danish Register of Causes of Death.
Participants registered with accident as a cause of contact in the
Danish National Patient Register were defined as a case if they had one
or more cause of contact that indicated involvement in a traffic accident
(diagnosis ICD-10: Z041, accident-code: EUK0, EUG0 plus EUA0 or
EUA2 or EUHD01). Cases registered as a pedestrian (EUP1) or pas-
senger (EUHD02, EUT2-EUT5) were excluded. Participants with
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transport accidents (ICD-10: V01-V99) as an underlying cause of death
from the Danish Register of Causes of Death were also defined as cases.
2.6. Controls
Frequency matched controls were selected among the 81,912 DBDS
participants and matched for age (age at time of blood sampling in
completed years) and sex for the 5953 cases. For each sex and age
matched group, 20% more controls than cases were chosen (N=7101,
of whom 554 were also a case) giving a total number of 12,500 cases
and controls. To allow using controls between different outcomes,
controls were not conditioned to be healthy. This was handled in the
specific analyses for each outcome.
2.7. Immunological assays
Plasma samples from blood donations were initially collected in
5ml plasma preparation tubes (K2EDTA/Gel), centrifuged and frozen
within 6 h after blood collection. For this study all 81,912 plasma
samples were thawed and transferred to Thermo Scientific Matrix tubes
with 2D Codes on the bottom, before selection of cases and controls.
The 12,500 selected plasma samples for cases and controls were
randomized into three batches and transferred to the Stanley
Neurovirology Laboratory for analysis of specific enzyme-based im-
munoassays for immunoglobulin (IgG) class antibodies against T. gondii
and CMV, previously described (Dickerson et al., 2003). The raw IgG
antibody titer values were standardized across plates and the distribu-
tion of this standardized z-score was fitted with two normal distribu-
tions to determine the cut-off value for each batch and each infectious
agent (Supplemental Figs. 1 and 2). The cut-off was determined to
match the area under the tails in the two normal distributions. If the
individual had a value above this cut-off, it was considered that the
person had been exposed to the infectious agent.
2.8. Statistical methods
After sample-analysis and quality control, statistical analysis was
conducted on 11,546 cases and controls.
A conditional logistic regression model was used to analyze the
associations between T. gondii and CMV and the risk of psychiatric
disorders, suicidal behavior, and traffic accidents forming strata for
frequency matched sets. By design, we controlled for sex and age at
time of blood sampling, therefore age and sex are not directly included
in the conditional logistic regression. Additionally, we conducted an
analysis where toxoplasmosis and CMV were mutually adjusted, and all
analyses were adjusted for parental history of psychiatric disorder be-
fore time of blood collection, as previously described (Pedersen et al.,
2011). Odds ratios (ORs) and 95% likelihood ratio confidence intervals
(95% CIs) were calculated. A two-sided P value of less than 0·05 was
considered to be statistically significant. Statistical analyses were per-
formed using the PHREG procedure in SAS 9·3 (SAS Institute, Cary,
North Carolina). We also calculated the batch specific estimates
(Supplemental Figs. 3 and 4).
The nested case-control study was conducted to account for tem-
porality, i.e., the exposure should precede the outcome of interest to
fulfill Hills viewpoints of causality (Rothman et al., 2008). For each
outcome of interest, we included only individuals with onset after the
date of blood sample collection and conducted conditional logistic re-
gression for these cases and their time-, age- and sex-matched controls.
The estimates thus obtained are informative for the risk of developing
the outcomes of interest following exposure to T. gondii or CMV i.e.,
incidence rate ratios (Pearce, 1993; Vandenbroucke and Pearce, 2012).
2.9. Ethics
The Ethics Committee of Central Denmark (M-20090237) and The
Danish Data Protection Agency (2007-58-0015) have previously ap-
proved the study. The Danish Data Protection Agency approved the
transport and analysis of plasma samples to the Stanley Neurovirology
Laboratory. The National Board of Health approved the use of registry
data. Data will be kept confidential under the law concerning proces-
sing of personal data. Written informed consent was obtained from all
participants.
3. Results
Register data on 81,912 individuals were reviewed to find in-
dividuals who had been diagnosed with psychiatric disorders, had at-
tempted or committed suicide, and/or had been involved in traffic ac-
cidents, resulting in a total of 12,500 cases and controls. After sample
analysis and quality control, statistical analysis was conducted on
11,546 cases and controls, see distribution of cases and controls (non-
exclusive) in Table 1. A total of 5492 individuals (2807 women) were
registered with a psychiatric disorder, suicide or suicide attempt, or
traffic accident. Overall, 2591 individuals (1314 women) were regis-
tered in the Danish Psychiatric Central Research Register with a
Table 1
Odds ratios and incidence rate ratios of toxoplasmosis and CMV on psychiatric disorders, suicide and traffic accident.
Case-control study Nested case-control study
Odds ratios Incidence rate ratios*
Case Control T. gondii CMV Case Control T. gondii CMV
N N OR (95%CI) OR (95%CI) N N IRR (95%CI) IRR (95%CI)
Any psychiatric disorders (F00-F99) 2,591 6,331 1·03 1·17 325 5,109 1·05 (0·80;1·38) 1·37 (1·08;1·74)
(0·93;1·15) (1·06;1·29)
Schizophrenia and related disorders 151 6,550 1·47 1·25 28 5,293 2·78 (1·27;6·09) 1·34 (0·61;2·92)
(F20-F29) (1·03;2·09) (0·89;1·77)
Mood disorders (F30-F39) 711 6,501 0·89 (0·73;1·07) 1·09 147 5,254 0·92 (0·61;1·38) 1·43 (1·01;2·04)
(0·92;1·28)
Neurotic, stress-related, and somatoform disorders (F40-F48) 1,385 6,430 1·05 1·27 208 5,192 1·09 (0·78;1·51) 1·20 (0·89;1·60)
(0·92;1·21) (1·12;1·44)
Suicide or suicide attempt 655 6,503 1·13 1·31 23 5,259 0·45 1·18
(0·94;1·36) (1·10;1·56) (0·13;1·55) (0·50;2·82)
Traffic accident 2,724 6,294 1·11 1·06 751 5,228 1·18 (0·99;1·41) 1·15 (0·98;1.35)
(1·00;1·23) (0·97;1·17)
Adjusted for sex and age due to design and parental history of psychiatric disorder.
‘bold’ indicates a likelihood ratio based 95% p-value < 0·05
‘*’ We accounted for temporality by excluding individuals with outcome of interest before the date of blood sample collection, i.e. past infection with T. gondii and
CMV should precede the outcome of interest, estimating incidence rate ratios.
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psychiatric diagnosis, 655 (377 women) had attempted or committed
suicide, and 2724 individuals (1233 women) had been involved in a
traffic accident. The average age at blood donation was 37.4 years in
the study population; age distribution is shown in Supplemental Fig. 5.
3.1. Infection with T. gondii and CMV
Of the 11,546 studied individuals, 2990 and 7020 individuals, re-
spectively, tested positive for IgG class antibodies against T. gondii
(25·9%) or CMV (60·8%). For a more detailed overview of the number
of infected/non-infected cases and controls for each health outcome,
see Supplemental Table 1.
We found that individuals with a T. gondii infection had increased
odds of being diagnosed with schizophrenia disorders compared to
those without infection (OR, 1·47; 95% CI, 1·03–2·09) (Table 1). The
association was even stronger when accounting for temporality and
considering only the 28 cases who were diagnosed with a schizophrenia
disorder after the date of blood collection (IRR, 2·78; 95% CI,
1·27–6·09) (Table 1). A very weak association between toxoplasmosis
and involvement in traffic accidents was observed in 9018 individuals
(OR, 1·11; 95% CI, 1·00–1·23) also when including only individuals
with traffic accident after blood donation (IRR, 1·18; 95% CI, 0·99–1·41)
(Table 1). Besides schizophrenia, T. gondii infection was not statistically
significantly associated with any other psychiatric disorder, whether
overall (OR, 1·03; 95% CI, 0·93–1·15), or more specifically, i.e. mood
disorders (OR, 0·89; 95% CI, 0·73–1·07), neurotic, stress-related, and
somatoform disorders (OR, 1·05; 95% CI, 0·92–1·21), or attempting or
committing suicide (OR, 1·13; 95% CI, 0·94–1·36) (Table 1).
CMV infection was associated with increased risk of: any psychiatric
disorder (OR, 1·17; 95% CI, 1·06–1·29), neurotic, stress-related and
somatoform disorders (OR, 1·27; 95% CI, 1·12–1·44) and attempting or
committing suicide (OR, 1·31; 95% CI, 1·10–1·56) (Table 1). Con-
sidering only cases with an outcome after the date of blood donation,
CMV infection was still statistically significantly associated with any
psychiatric disorder (IRR, 1·37; 95% CI, 1·08–1·74) but not with at-
tempting or committing suicide (IRR, 1·18; 95% CI, 0·50–2·82). In ad-
dition, CMV infection was found only to be associated with mood dis-
orders (IRR, 1·43; 95% CI, 1·01–2·04) after excluding individuals with
onset pre-dating blood sample collection (Table 1). CMV infection was
not statistically significantly associated with schizophrenia and related
disorders (OR, 1·25; 95% CI, 0·89–1·77) or with traffic accidents (OR,
1·06; 95% CI, 0·97–117) (Table 1). Mutual adjustment of CMV and
toxoplasmosis did not change the overall findings (Supplemental
Table 2).
4. Discussion
This largest to date serological study provides evidence that ex-
posure to T. gondii might be a contributing causal factor for developing
schizophrenia and that exposure to CMV might be a contributing causal
factor for developing serious psychiatric disorders.
Research suggests that changes in dopamine levels are involved in
the pathogenesis of toxoplasmosis-associated behavior changes in hu-
mans. These include prolongation of reaction time, decreased long-term
concentration, decreased cognition and specific changes in neurode-
generative- and psychiatric disorders (Flegr et al., 2003).
The Toxoplasma genome carries two genes encoding dopamine-
synthesizing enzymes (tyrosine hydroxylase) (Gaskell et al., 2009;
Henriquez et al., 2009). Dopamine is produced and secreted in large
amounts in Toxoplasma cysts in the brain tissue of infected rodents
(Martin et al., 2015; Prandovszky et al., 2011) and most likely in hu-
mans as well (Flegr et al., 2003; Henriquez et al., 2009; McConkey
et al., 2013; Skallová et al., 2005). It has been shown that latent (but
not acute) T. gondii infection in mice elevates the local brain dopamine
concentrations, as observed in individuals with schizophrenia (Eyles
et al., 2012; Henriquez et al., 2009). This increased dopamine level may
be responsible for toxoplasmosis-associated behavior changes.
Human cognition may be affected by exposure to T. gondii, as severe
congenital toxoplasmosis can lead to mental retardation (Nissen et al.,
2017). Even among “unaffected” children with congenital tox-
oplasmosis, high maternal antibody titres during pregnancy are asso-
ciated with delayed mental development in their first year and an in-
creased risk of having an IQ less than 70 at 7 years (Sever et al., 1988).
Human cognition and behavior may also be affected by postnatal T.
gondii infection. In schoolchildren, Toxoplasma seropositivity has been
associated with lower mathematics (Ferreira et al., 2013) and reading
skills but also poorer memory capacity (Mendy et al., 2015a,b). Several
studies have also shown a negative effect of T. gondii on cognition in
adults and the elderly (Dickerson et al., 2014a; Gajewski et al., 2014;
Hamdani et al., 2017; Mendy et al., 2015a,b; Nimgaonkar et al., 2016;
Wyman et al., 2017).
Infections have been associated with cognitive and behavior
changes in humans. Prenatal exposure to a range of infections and in-
flammatory responses may be associated with increased risk of adult
schizophrenia (Khandaker et al., 2013). Infections in early childhood
have been found to have negative effects on human cognition and in-
creased risk of nonaffective psychosis. The association between infec-
tion and non-affective psychosis is mediated and moderated by IQ
(Khandaker et al., 2018).
The immunological reaction to a parasite infestation may disrupt
tryptophan metabolism, as parasite-infected cells secrete large amounts
of kynurenic acid (KYNA) via indoleamine-2,3-dioxygenase (IDO)-
mediated tryptophan degradation (Henriquez et al., 2009; McConkey
et al., 2013). Latent T. gondii infection leads to the production of the
rate-limiting enzyme IDO and tryptophan dioxygenase (TDO) in astro-
cytes (Campbell et al., 2014; Henriquez et al., 2009; McConkey et al.,
2013; Nagineni et al., 1996). This leads to decreased levels of trypto-
phan, necessary for the growth and replication of T. gondii, but more-
over, leads to the production of some harmful metabolites such as
KYNA. Tryptophan is degraded by IDO to kynurenine, which is either
metabolized to KYNA, an antagonist of the glutamate N-methyl-D-as-
partate (NMDA) and nicotinic receptors (Campbell et al., 2014;
Henriquez et al., 2009; Kessler et al., 1989) or hydroxylated to quino-
linate, a potent NMDA neurotoxic agent (El-Defrawy et al., 1986). High
levels of KYNA are found in the cerebrospinal fluid of schizophrenic
individuals, and may plausibly cause cognitive disorders in schizo-
phrenia (Henriquez et al., 2009). Tryptophan is also the essential pre-
cursor of serotonin, which is involved in depressive disorders. Hence,
both dopaminergic and glutamatergic systems are affected by T. gondii
and could represent the mediating factors between toxoplasmosis and
psychiatric disease.
A causal relationship between serological evidence of exposure to
Toxoplasma and psychiatric disorders has been well studied in in-
dividuals with schizophrenia (Flegr and Horáček, 2018; Hamdani et al.,
2017; Sutterland et al., 2015; Torrey et al., 2012, 2007). We found a
statistically significant association between serological evidence of ex-
posure to Toxoplasma and schizophrenia or related disorders, compared
to controls. An even stronger statistically significant association was
observed between serological evidence of exposure to Toxoplasma and
schizophrenia after excluding participants whose diagnosis preceded
blood sample collection. This corroborates that Toxoplasma has a po-
sitive effect on the rate of schizophrenia and that T. gondii infection
might be a contributing causal factor for schizophrenia. Similarly, a
meta-analysis including all available studies analyzing the association
between T. gondii infection and schizophrenia reported an increased
odds ratio of 2·73 (Torrey et al., 2007). This level of association exceeds
both the genetic and most other environmental risk factors for schizo-
phrenia to date (Torrey et al., 2012), supporting the close relation be-
tween T. gondii infection and schizophrenia.
It has been found that individuals with higher titers of IgG class
antibodies on T. gondii often show more severe symptoms of psychosis
and a correlation between toxoplasmosis and increased mortality in
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schizophrenic patients has been observed (Dickerson et al., 2007;
Torrey et al., 2007). Interestingly, many anti-psychotic drugs com-
monly used in the treatment of schizophrenic patients have anti-T.
gondii activity and may inhibit the replication and invasion of T. gondii
in infected individuals (Gutiérrez-Fernández et al., 2015). It has been
shown that schizophrenic patients treated with anti-psychotic drugs
have lower levels of antibodies to T. gondii compared to untreated
schizophrenic patients (Leweke et al., 2004). One could argue that the
effect of anti-psychotic drugs in schizophrenic patients may be partly
due to the inhibition of T. gondii activity.
Toxoplasma-associated behavior changes could result in decreased
concentration and prolonged reaction time, which could increase the
risk of traffic accidents. We found a very weak statistical association
between T. gondii infection and risk of traffic accidents. Previous studies
have found a 2–4 times higher risk of traffic accidents in individuals
with T. gondii infection compared to non-infected individuals (Flegr
et al., 2002; Flegr and Dama, 2014; Stepanova et al., 2017). Interesting,
the only existing prospective cohort study on traffic accidents and
toxoplasmosis found a significant association between traffic accidents
and toxoplasmosis only in RhD-negative individuals, and not in RhD-
positive individuals or in the non-sorted population (Flegr et al., 2009).
The difference in RhD status could also apply to our study and may
explain why we only found a very weak association between tox-
oplasmosis and traffic accidents. A recent systematic review and meta-
analysis concluded that exposure to T. gondii significantly increases the
risk of having traffic accidents (Gohardehi et al., 2018) which our re-
sults also supports. In addition, T. gondii infected individuals have been
found also to have an increased risk of workplace accidents (perhaps
due to decreased concentration and prolonged reaction times)
(Alvarado-Esquivel et al., 2012) and of starting their own business
(Johnson et al., 2018), but not of increased financial risk-taking
(Lanchava et al., 2015).
Besides T. gondii infection, herpesvirus, such as CMV, infection has
also been associated with psychiatric disorders, schizophrenia, mood
disorders, decreased cognitive functioning, and suicide in seriously
mentally ill individuals (Dickerson et al., 2017, 2014b; Hamdani et al.,
2017; Prossin et al., 2015). Infections like CMV may cause alterations in
the immune inflammatory cascades and have an impact on brain
function through neuroinflammation (Tanaka et al., 2017).
In our study, CMV was statistically significantly associated with
having any psychiatric disorder. An even stronger association was ob-
served when including only individuals diagnosed after blood collec-
tion. CMV was more strongly associated with a more selected group of
neurotic, stress-related, and somatoform disorders. This group might
drive the observed effect in any psychiatric disorder, and a post hoc
analysis showed that CMV infection had no impact on the risk of any
psychiatry excluding F40-F48 (OR=1·06, 95% CI 0·94–1·21,
IRR=1·41, 95%CI 0·99–2·00). Studies have showed that higher CMV-
IgG levels are associated with increased anxiety, depression, vital ex-
haustion (lack of energy, increased irritability, and feelings of demor-
alization) and decreased SF-12 mental health (Phillips et al., 2008;
Rector et al., 2014; Trzonkowski et al., 2004). Higher CMV-IgG levels
reflect poorer immune control and reactivation of the virus (Glaser and
Kiecolt-Glaser, 1994; Kuo et al., 2008; van Zanten et al., 1995), which
may be triggered by psychological stress, representing a potential me-
chanism linking stress and immunity (Bosch et al., 2013).
Prossin et al. also found that a higher IgG concentration against
CMV was associated with elevated mood states in bipolar disorders
compared to healthy controls. In addition, CMV IgG was higher in in-
dividuals with bipolar disorder with elevated moods but not different in
depressed moods when compared with euthymic bipolar disorder in-
dividuals (Prossin et al., 2015). We found a statistically significant as-
sociation between CMV and mood disorder, but only in individuals
diagnosed after the date of blood collection. In our analysis, we com-
bined all diagnoses of mood disorders (ICD-10: F30-F39) into one ca-
tegory, whereas Prossin et al. focused only on bipolar disorder (ICD-10:
F30-31) (Prossin et al., 2015). Our analysis was based on a more diverse
group of mood disorders and is not suitable for demonstration of a
statistically significant association between CMV and a specific mood
disorder, such as bipolar disorder, due to the small numbers of cases
(N= 57).
Previous studies have reported an association between in-
flammatory processes, such as infectious agents, and suicide. We found
that CMV infection was statistically significantly associated with at-
tempting or committing suicide. Taking only suicide or suicide attempts
after blood donation into account, no association was observed, which
might be due to the small number of individuals with suicide or suicide
attempts after blood collection. Only two studies to date have addressed
the association between CMV and suicide, and found an association
between CMV and suicide attempts in individuals with serious mental
illness (Dickerson et al., 2018, 2017). The observed association between
CMV and suicide attempt may be due to the direct effect of the mi-
croorganisms altering the level of dopamine and other neuro-
transmitters, or due to the immune response altering the activity of toll-
like receptors in response to CMV, which has also been shown to be
altered in brains of individuals with completed suicide attempts
(Pandey et al., 2014).
The effect of coinfection with T. gondii and CMV and the association
with psychiatric disorders, suicidal behavior or traffic accidents did not
influence the overall results.
Our study has several strengths. This case-control study is the lar-
gest serological study to date of T. gondii and CMV infection in relation
to psychiatric disorders, self-violence and risk-taking behavior in a
nation-wide population. Another strength of this study was that we
accounted for temporality in the nested case-control study, i.e., the
pathogen exposure should precede the outcome of interest to show
possible causality. A limitation of this study was that we did not control
for socio-economic factors, which may influence the probability of
pathogen infection, development of psychiatric disorders, suicidal be-
havior, or involvement in traffic accidents. A study of the socio-de-
mographic characteristics of the DBDS population showed that the
middle to high income groups, but not the highest income group, had
fourfold higher donor prevalence than the lowest income group (6.7%
compared to 1.7%) and that social marginalization, as indicated by low
income and being a male living without a woman, was associated with
lower prevalence of blood donation (Burgdorf et al., 2017). We cannot
rule out that socio-economic factors could potentially account for part
or all of the observed causaleffect. The link between family history of
psychiatric disorder and psychiatric disorders or suicidal behavior is
well established (Dean et al., 2010). However, adjusting for parental
history of psychiatric disorders did not influence the overall results. In
this study, the prevalence of any psychiatric disorders was lower than
the national lifetime risk of mental disorders (Pedersen et al., 2014).
This may be due to the fact that the blood donor population is a highly
selected population who are healthier than the general population, and
since older blood donors are a highly selected group of individuals (the
healthy donor effect), the generalizability to other settings may be
limited.
In conclusion, our study finds that T. gondii infection might be a
contributing causal factor for schizophrenia. Moreover, T. gondii in-
fection was borderline significantly associated with traffic accidents.
CMV infection may be a risk factor for developing any psychiatric
disorder, especially neurotic, stress-related, and somatoform disorders,
or for experiencing self-violence in the form of attempting or commit-
ting suicide. Although we did not control for socio-economic factors,
which may have an effect on health outcome, we were able to account
for temporality of pathogen exposure. Our findings support the growing
scientific evidence linking pathogenic infection with serious psychiatric
disorders. Routinely screening for T. gondii and CMV in populations
with psychiatric disorders may identify novel stratification groups,
which can be used to target treatment e.g. in combination with analysis
of genetic risk factors. Likewise, targeting T. gondii or CMV infections
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can provide novel therapeutic approaches as well as potential bio-
markers to identify individuals at increased risk. A detailed under-
standing of the origin, mechanisms and outcomes of these pathogenic
infections in relation to psychiatric disorders, self-violence and risk-
taking behavior is necessary in order to improve detection and treat-
ment.
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